Adm1n: Created page with "JWH-175 is a drug from the naphthylmethylindole family which acts as a cannabinoid receptor agonist. It was invented by the scientist John W. Huffman and colleagues at..."

2015-02-16T14:42:58Z

Created page with "JWH-175 is a drug from the naphthylmethylindole family which acts as a cannabinoid receptor agonist. It was invented by the scientist John W. Huffman and colleagues at..."

New page

JWH-175 is a drug from the naphthylmethylindole family which acts as a [[cannabinoid receptor]] agonist. It was invented by the scientist [[John W. Huffman]] and colleagues at Clemson University. JWH-175 is closely related to the widely used [[cannabinoid]] designer drug [[JWH-018]], but with the ketone bridge replaced by a simpler methylene bridge. It is several times weaker than JWH-018, having a binding affinity at the [[CB1]] receptor of 22nM, though some derivatives substituted at the 4-position of the naphthyl ring have potency more closely approaching that of the equivalent naphthoylindoles. This makes JWH-175 considerably less potent than most synthetic cannabinoid drugs used in [[Synthetic Cannabis]] blends, and it is unclear if JWH-175 has ever been used for this purpose. However it has still been explicitly banned in several jurisdictions including Russia and some Australian states, in order to stop its potential use as an ingredient in such products.

==See also==

* [[JWH-176]]

* [[JWH-184]]

* [[JWH-185]]

JWH-175 - Revision history

Adm1n: Created page with "JWH-175 is a drug from the naphthylmethylindole family which acts as a cannabinoid receptor agonist. It was invented by the scientist John W. Huffman and colleagues at..."